pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
DYNE-302
Facioscapulohumeral Muscular Dystrophy (FSHD)
$DYN
Dyne Therapeutics, Inc.
0
catalysts
Preclinical
DaRT-101
Osteoarthritis
Darnatein
0
catalysts
Phase 2
Decoy-20
Adenoid Cystic Carcinoma (ACC)
$INDP
Indaptus Therapeutics, Inc.
0
catalysts
Preclinical
Dekaparin
← prev
page 79 of 231
next →
131
Pain
89
Neurology
1
Deep Vein Thrombosis (DVT)
Glycan Therapeutics Inc
0
catalysts
Phase 1
Deltacel
Non-Small Cell Lung Cancer
Immunocell Therapeutics Inc
0
catalysts
Phase 1
Dendocrin
Secondary Hyperparathyroidism
Novadiol Inc
0
catalysts
Phase 3
Descartes-08
Myasthenia Gravis
$RNAC
Cartesian Therapeutics, Inc.
0
catalysts
Marketed
Desowen
Desonide Actavis (desonide)
Psoriasis
Teva Pharmaceuticals USA Inc
0
catalysts
Phase 1
Diakine-DK210 (EGFR)
Bladder Cancer
Deka Biosciences Inc
0
catalysts
Preclinical
DisPATCH
Solid Tumor
RootPath Genomics Inc
0
catalysts
Marketed
Dorlan
Flurbiprofen (flurbiprofen)
Osteoarthritis Pain
Teva Pharmaceuticals USA Inc
0
catalysts
Marketed
Doxorubicin Teva
Doxorubicin Hydrochloride (doxorubicin)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Teva Pharmaceuticals USA Inc
0
catalysts
Preclinical
Drug for Anal Fissure
Anal Fissure
Steel Therapeutics Inc
0
catalysts
Phase 1
Drug for Unspecified Dermatological Disorders
Unspecified Dermatological Disorders
Neutrophil collagenase
Interstitial collagenase
TBT Pharma Inc
0
catalysts
Preclinical
Drug to Inhibit MDM2 for Retinoblastoma
Retinoblastoma
Spectocular LLC
0
catalysts
Preclinical
Drugs for Oncology
Pancreatic Ductal Adenocarcinoma
SRI International
0
catalysts
Phase 1
E-1018
Malaria
Eisai Co Ltd
0
catalysts
Preclinical
E-1V111
Spinal Muscular Atrophy (SMA)
Shift Pharmaceuticals
0
catalysts
Phase 1
E-2025
Alzheimer's Disease
Eisai Co Ltd
0
catalysts
Phase 1
E-2086
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
Eisai Co Ltd
0
catalysts
Phase 1
E-2511
Alzheimer's Disease
Eisai Co Ltd
0
catalysts
Phase 1
E-7766
Solid Tumor
Eisai Co Ltd
0
catalysts
Preclinical
EB-002
Anxiety Disorders
MycoMedica Life Sciences PBC
0
catalysts
Preclinical
EB-003
Hemolytic Uremic Syndrome
Eligo Bioscience SA
0
catalysts
Preclinical
EB-07
paridiprubart [INN]
Pulmonary Fibrosis
$EDSA
Edesa Biotech, Inc.
0
catalysts
Phase 2
EB-103
B-Cell Non-Hodgkin Lymphoma
$ESLA
Estrella Immunopharma, Inc.
0
catalysts
Preclinical
EB-104
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$ESLA
Estrella Immunopharma, Inc.
0
catalysts
Phase 1
EB-105
Diabetic Macular Edema
Eluminex Biosciences Ltd
0
catalysts
Phase 1
EBC-129
Pancreatic Ductal Adenocarcinoma
Agency for Science, Technology and Research
0
catalysts
Phase 2
EBT-101
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Excision BioTherapeutics Inc
0
catalysts
